17 Parkinsons Disease Clinical Trials in Aurora, IL (2026)

Q: How do I join a clinical trial in Aurora?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you.

Recruiting Parkinsons Disease Studies in Aurora

NCT04994015Recruiting

Parkinson's Foundation PD GENEration Genetic Registry

Development of a central repository for PD-related genomic data for future research....

Aurora, IL25,000 participantsParkinson's Foundation

View Study Details

NCT04477785Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative (PPMI) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biolo...

Aurora, IL4,500 participantsMichael J. Fox Foundation for Parkinson's Research

View Study Details

NCT02071134Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease. ...

Aurora, IL1,500 participantsBoston Scientific Corporation

View Study Details

NCT07684820Recruiting

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study dru...

Aurora, IL600 participantsExpedition Therapeutics, Inc

View Study Details

NCT04373317Recruiting

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients also have other sympt...

Aurora, IL358 participantsVA Office of Research and Development

View Study Details

NCT06680830Recruiting

A Phase 2 Study of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the ...

Aurora, IL150 participantsNeuron23 Inc.

View Study Details

NCT05937854Recruiting

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

The investigators will study whether the drug tadalafil improves shortness of breath in 126 Veterans with Chronic Obstructive Pulmonary Disease (COPD) and high blood pressure in the lungs. The investi...

Aurora, IL126 participantsVA Office of Research and Development

View Study Details

NCT06944522Recruiting

A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease

Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of bemdaneprocel in approximately 102 adults with Parkinson's Disease...

Aurora, IL102 participantsBlueRock Therapeutics

View Study Details

NCT05896579Recruiting

Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

This study plans to learn about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of right ...

Aurora, IL60 participantsUniversity of Colorado, Denver

View Study Details

NCT07576894Recruiting

Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary Disease

This study plans to learn more about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of r...

Aurora, IL60 participantsUniversity of Colorado, Denver

View Study Details

NCT06446505Recruiting

Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease

The goal of this clinical trial is to learn if a Decision Aid can help patients with Parkinson's disease make a decision about undergoing Deep Brain Stimulation surgery. The main questions it aims to ...

Aurora, IL42 participantsUniversity of Colorado, Denver

View Study Details

NCT05292794Recruiting

Use of CereGate Therapy for Freezing of Gait in PD

A Multi-Center, Controlled Study to Evaluate Use of CereGate Therapy to Reduce Freezing of Gait in Participants Diagnosed with Parkinson's Disease....

Aurora, IL41 participantsCereGate Inc.

View Study Details

NCT07498296Recruiting

Adapting rHIRE and Sleep Monitoring in Parkinson's Disease

Exercise is a primary intervention for symptom management in Parkinson's Disease (PD). However, challenges related to transportation, mobility, and socioeconomic factors often hinder consistent partic...

Aurora, IL16 participantsUniversity of Colorado, Denver

View Study Details

NCT05348837Recruiting

Naturalistic Sleep Assessed by Wearable Devices in Parkinson Disease

The cardinal motor features of Parkinson's disease (PD) include bradykinesia, rest tremor, and rigidity. Though non-motor features have been recognized for centuries, only recently has the prevalence ...

Aurora, IL15 participantsUniversity of Colorado, Denver

View Study Details

NCT06778135Recruiting

Neocortical Microarchitecture of Executive Function

This study is being done to the determine the ability and utility of using the Neuropixels probes in the human brain. A Neuropixels probe will be inserted into and removed from the brain of awake huma...

Aurora, IL15 participantsUniversity of Colorado, Denver

View Study Details

NCT07030283Recruiting

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

This goal of this clinical trial is to learn whether the drug combination of intraperitoneal paclitaxel (chemotherapy given directly into the abdominal cavity) and intravenous NALIRIFOX (chemotherapy ...

Aurora, IL10 participantsUniversity of Colorado, Denver

View Study Details

NCT06296810Recruiting

Adaptive DBS to Offset STN Dysregulation During Exercise in PD

The investigators conduct a prospective study to evaluate the effects of exercise on Parkinson's Disease brain biomarkers detected with the PerceptTM PC neurostimulator....

Aurora, IL10 participantsUniversity of Colorado, Denver

View Study Details

About Parkinsons Disease Clinical Trials in Aurora

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 17 parkinsons disease clinical trials recruiting participants in Aurora, IL. These studies are seeking a combined 32,605 participants. Research is being sponsored by Parkinson's Foundation, Michael J. Fox Foundation for Parkinson's Research, Boston Scientific Corporation and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in Aurora — FAQ

Are there parkinsons disease clinical trials in Aurora?

Yes, there are 17 parkinsons disease clinical trials currently recruiting in Aurora, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Aurora?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.

Are clinical trials in Aurora free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 17 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 13, 2026 from ClinicalTrials.gov